See also this year's filing and all EDGAR filings for this company.
PDF Report 0001651407_2023_Checkpoint_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001651407, Checkpoint Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 13,290,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 32,773,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,700,000 |
| 9 | ResearchAndDevelopmentExpense | 49,825,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 192,000 |
| 12 | remainder_NetIncome | -4,291,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,290,000 |
| 1 | Liabilities | 32,773,000 |
| 2 | Expenses | 58,525,000 |
| 3 | Revenues | 192,000 |
| 4 | StockholdersEquity | -19,483,000 |
| 5 | NetIncome | -62,624,000 |
| 6 | ComprehensiveNetIncome | -62,624,000 |
| 7 | BaseVar | 54,535,500 |
| 8 | EconomicCapitalRatio | -4.17 |
Edgar->Model Mapping
Feature Distribution
Change over Time
